Are Pet Food Recalls Rising?
Pet food recalls hit their highest level in 5 years in 2023, with numbers this year almost equaling those from previous years ...
Scientific American2d
How a Chemist and His ‘Poison Squad’ Inspired the First Food Safety Regulations
Author and science journalist Deborah Blum describes how an Indiana chemist kicked off the first major food regulation in the ...
The AI effect: How a hot computing tool is tying ‘bio’ and ‘tech’ closer than ever
The rise of AI in biotech also comes with common caveats as money flows to AI drug developers with the promise of producing ...
Louisiana Republicans declare abortion pills a "dangerous substance," threaten prison and hard labor
Under the proposed law, someone who is themselves pregnant would be exempt from imprisonment and fines, but anyone who helps ...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her ...
Oklahoma included in Pedigree dog food recall. See if your pet's food is affected
Oklahoma is one of four states where certain bags of Pedigree dog food are being recalled from store shelves. Many Oklahomans ...
Louisiana abortion drug bill latest front in post-Dobbs fight
Louisiana is close to classifying two drugs used in medication abortion and miscarriage management as “controlled dangerous ...
Hims & Hers is getting into the weight-loss drug game — and Wall Street is loving it
Hims & Hers compounded GLP-1 — the same ingredient as Ozempic — will be priced at $200 a month. Investors are loving the ...
US FDA approves Amgen drug for small cell lung cancer
The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted ...
Biogen is buying up an immune drug developer for $1.8 billion
Biotechnology giant Biogen said on Wednesday that it is acquiring immune drug developer Human Immunology Biosciences (HI-Bio) ...
Recent FDA committee vote could speed multiple myeloma drug approval
A U.S. Food and Drug Administration committee voted unanimously in April to approve a new clinical endpoint, minimal residual ...
U.S. Food and Drug Administration (FDA) Extends its Memorandum of Understanding (MOU) with MedISAO
MedISAO, an organization composed of members of the medical device manufacturer community dedicated to improving medical device security through education, awareness, and advocacy, announced today its ...